Montaser Alaa, Driscoll Jessica, Smith Hudson, Karsten Madeline B, Day Emily, Mounlavongsy Tina, Orbach Darren B, Smith Edward R
Departments of1Neurosurgery and.
2Radiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; and.
J Neurosurg Pediatr. 2021 Jul 2;28(3):351-359. doi: 10.3171/2021.2.PEDS20743. Print 2021 Sep 1.
Isolated anterior cerebral artery (ACA) territory ischemia in pediatric moyamoya disease (MMD) is rare but has been increasingly recognized, particularly in children manifesting progression of disease in a delayed fashion after middle cerebral artery revascularization surgery. Surgical treatment is complicated by limited graft choices, with the small number of case series largely focused on complex, higher-risk operations (omental flap transfers, large interhemispheric rotational grafts); direct bypass (often untenable in children due to vessel size); or, alternatively, the technically simpler method of multiple burr holes (of limited efficacy outside of infants). Faced with the problem of a growing cohort of pediatric patients with MMD that could benefit from anterior cerebral revascularization, the authors sought to develop a solution that was specifically designed for children and that would be lower risk than the more complex approaches adapted from adult populations but more effective than simple burr holes. In this study, the authors aimed to describe the long-term clinical and radiographic outcomes of a novel approach of pial pericranial dural (PiPeD) revascularization, building on the principles of pial synangiosis but unique in using the pericranium and the dura mater as the primary vascular supply, and employing a larger craniotomy with arachnoid dissection to provide robust full-territory revascularization in all ages with reduced risk relative to more complex procedures.
The medical records of all pediatric patients with MMD who presented at a single center between July 2009 and August 2019 were retrospectively reviewed to identify patients with MMD with anterior cerebral territory ischemia. Clinical characteristics, surgical indications, operative techniques, and long-term clinical and radiographic follow-up data were collected and analyzed.
A total of 25 operations (5.6% of total procedures) were performed in 21 patients (mean age 9.4 years [range 1-16.5 years]; 12 female and 9 male). Almost one-third of the patients had syndromic associations, with no familial cases. Complications included 1 patient (4.7%) with a superficial infection, with no postoperative strokes, hemorrhage, seizures, or deaths. Long-term follow-up was available in 18 of 21 patients (mean 24.9 months [range 4-60 months]). Radiographic engraftment was present in 90.9% (20/22 hemispheres), and no new strokes were evident on MRI on long-term follow-up, despite radiographic progression of the disease.
The use of the pericranium and the dura mater for indirect revascularization provided robust vascularized graft with great flexibility in location and high potential for engraftment, which may obviate more complex and higher-risk operations for ACA territory ischemia. Long-term follow-up demonstrated that PiPeD revascularization conferred durable, long-term radiographic and clinical protection from stroke in pediatric patients with MMD. Based on the results of the current study, the PiPeD technique can be considered an additional tool to the armamentarium of indirect revascularization procedures in select pediatric patients with MMD.
小儿烟雾病(MMD)中孤立的大脑前动脉(ACA)供血区缺血较为罕见,但已越来越受到关注,尤其是在大脑中动脉血运重建术后疾病呈延迟进展的儿童中。手术治疗因移植物选择有限而变得复杂,少数病例系列主要集中在复杂的、高风险的手术(网膜瓣转移、大型半球间旋转移植物);直接搭桥(由于血管尺寸问题,在儿童中往往不可行);或者,另一种技术上更简单的多骨孔方法(在婴儿以外的人群中疗效有限)。面对越来越多可从大脑前动脉血运重建中获益的小儿MMD患者这一问题,作者试图开发一种专门为儿童设计的解决方案,该方案的风险低于从成人中改编的更复杂方法,但比简单的骨孔更有效。在本研究中,作者旨在描述一种新型软膜-颅骨硬脑膜(PiPeD)血运重建方法的长期临床和影像学结果,该方法基于软膜吻合术的原理,但独特之处在于使用颅骨膜和硬脑膜作为主要血管供应,并采用更大的开颅术和蛛网膜分离术,以在所有年龄段提供强大的全区域血运重建,相对于更复杂的手术风险更低。
回顾性分析2009年7月至2019年8月在单一中心就诊的所有小儿MMD患者的病历,以确定患有ACA供血区缺血的MMD患者。收集并分析临床特征、手术指征、手术技术以及长期临床和影像学随访数据。
21例患者(平均年龄9.4岁[范围1 - 16.5岁];12例女性和9例男性)共进行了25次手术(占总手术的5.6%)。近三分之一的患者有综合征关联,无家族病例。并发症包括1例患者(占4.7%)发生浅表感染,无术后中风、出血、癫痫发作或死亡。21例患者中有18例获得长期随访(平均24.9个月[范围4 - 60个月])。影像学显示90.9%(22个半球中的20个)有植入,尽管疾病有影像学进展,但长期随访的MRI上未发现新的中风。
使用颅骨膜和硬脑膜进行间接血运重建提供了强大的血管化移植物,在位置上具有很大的灵活性且植入潜力高,这可能避免了针对ACA供血区缺血进行更复杂和高风险的手术。长期随访表明,PiPeD血运重建为小儿MMD患者提供了持久的、长期的影像学和临床中风保护。基于本研究结果,PiPeD技术可被视为特定小儿MMD患者间接血运重建手术工具库中的一种额外工具。